搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Opinion
coloradopolitics
1 小时
Opinion
A personal take from 2024 | Capitol M
But 2024 was anything but funny for your Capitol M. It started with an argument with my doctor over medication I've been ...
News Medical
5 小时
AI-based models can outperform human experts at identifying ovarian cancer
A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform ...
19 小时
Health Beat: New options to detect and treat ovarian cancer
Experts say ovarian cancer causes more deaths than all other female reproduction system cancers and is difficult to diagnose ...
The Economist
22 小时
Cancer vaccines are showing promise at last
The theory is solid, but creating such a bespoke vaccine quickly enough to be of use is a different matter. “Not many years ...
San Francisco Examiner
1 天
Closer to Cures at San Francisco's Gladstone Institutes
Time for some extremely good news: the cures for catastrophic diseases like cancer, Parkinson’s, heart disease and HIV are ...
Yahoo News UK
1 天
'I refused chemotherapy, now I'm one year tumour-free'
She was told a 15x9cm mass appeared to be coming from one of her ovaries. Recalling the conversation ... After an operation ...
The Himalayan Times
1 天
BRCA1 and BRCA2 tests possible in country
For the first time in Nepal, genetic testing, also known as "Gene Sequencing," related to breast cancer (BRCA1 and BRCA2) has ...
2 天
Devastated family say talcum powder linked to mum's cancer death
The family of Maureen Wright, who died of ovarian cancer in 1991, believe her use of talcum powder contributed to her death.
조선일보
2 天
Curocell develops Limkato, Korea's first CAR-T therapy with superior efficacy
Curocell launches Limcato, South Koreas first domestic CAR-T cancer therapy Curocell introduces first local CAR-T therapy, ...
Targeted Oncology
2 天
Novel CAR T-Cell Therapy Trial Advances to Third Cohort in Ovarian Cancer
A phase 1 trial evaluating FSHR-targeting CAR T cells for patients with ovarian cancer has dosed the first patient in its ...
Pharmaceutical Technology
2 天
Autologous SUPLEXA by Alloplex Biotherapeutics for Ovarian Cancer: Likelihood of Approval
Autologous SUPLEXA is under clinical development by Alloplex Biotherapeutics and currently in Phase I for Ovarian Cancer.
Pharmaceutical Technology
2 天
PAX-1 by Komipharm International for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
PAX-1 is under clinical development by Komipharm International and currently in Phase I for Kidney Cancer (Renal Cell Cancer).
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈